Open AccessBiopharmaceutics Classification System (BCS) Based Biowaiver Studies of Lenalidomide Capsules (25 mg) – An Alternative to In vivo Bioequivalence Studies for Generic Oncology Drug Products
Author(s) -
Mahmoud Alswisi,
Lassaad Boujbel,
Boujbel Mohamed Amine
Publication year - 2019
Publication title -
journal of bioequivalence and bioavailability
Language(s) - English
Resource type - Journals
ISSN - 0975-0851
DOI - 10.4172/0975-0851.1000386
Subject(s) - bioequivalence , biopharmaceutics , biopharmaceutics classification system , medicine , pharmacology , in vivo , lenalidomide , bioavailability , drug , multiple myeloma , chemistry , microbiology and biotechnology , in vitro , pharmacognosy , biology , biochemistry , biological activity